The spectrum of infections identified in pregnant women with different types of fetal growth restriction

Abstract

BACKGROUND: Bacterial, viral and protozoal infections can cause miscarriage, antenatal death, congenital organ abnormalities or other limited consequences depending on the pathogen. The role of infection processes identified during pregnancy on placental pathology and fetal growth restriction.

AIM: The aim of this study was to conduct a comparative analysis of infections identified in pregnant women with different types of fetal growth restriction, as well as to assess a potential impact of identified infections on the outcomes of fetal growth restriction in newborns in the same groups.

MATERIALS AND METHODS: We performed a retrospective analysis of outcomes for 394 pregnant women with an established diagnosis of fetal growth restriction, who had given birth from 2018 to 2022 in the Perinatal Center of the Arkhangelsk Regional Clinical Hospital. Maternal and neonatal case histories were obtained using a continuous sampling method. Considering the transition to new criteria for establishing the diagnosis of fetal growth restriction in Russia, we formed four study groups, of which only 139 cases met the Delphi criteria of clinical guidelines by Russian Society of Obstetricians and Gynecologists, 2021. In the selected groups, we analyzed the results of microscopic and microbiological tests of various localizations in mothers during antepartum examination, as well as postpartum examination of the placenta and culture tests in newborns in their relation to adverse outcomes.

RESULTS: A high prevalence (25–70.4%) of positive bacteriological findings was revealed in all of the study groups. The frequency was highest in the group of pregnant women with fetal growth restriction before 32 weeks (90–92%). Combined infections (two or more localizations) were noted in 59.2% of pregnant women in groups with early fetal growth restriction compared to 23.3% in late fetal growth restriction groups. In all cases, we observed a direct relationship between the severity of fetal growth restriction and the prevalence of infections. The range of infections identified during routine examination of pregnant women is quite limited; Candida spp. (from 40.8% in the control group to 75% in the comparison group), Escherichia coli (from 22.9 to 33.3%, respectively), and Chlamydia trachomatis (from 4.5 to 23.5%, respectively) being identified most commonly. In a morphological study of the placenta, infectious and inflammatory lesions were the most significant and ranged from 100 to 81.4% of cases in groups with early and late fetal growth restriction, respectively, with signs of hematogenous transmission prevailed. When analyzing infectious lesions in fetuses, we have found the presence of three and more localizations of the infectious process in 90 to 45% of cases with a fatal outcome for early and late fetal growth restriction, respectively. In the control groups, similar rates were 40 and 15.8%. When assessing the distribution of various types of infectious process in newborns, Candida spp., Escherichia coli, and Enterococcus faecalis also took the lead in all cases. However, the percentage of the same etiology of maternal and neonatal infections turned out to be very low (from 0 to 31% for individual pathogens), which makes it difficult to apply preventive treatment during pregnancy.

CONCLUSIONS: Authors identified indirect but numerous signs of significant involvement of infectious processes in the development of fetal growth restriction, especially its early type, as well as the influence of infections on the outcomes for such newborns. In most cases, infectious processes during pregnancy are subclinical. Current screening of pregnant women is insufficient to identify high-risk groups. Examination of pregnant women for infections carried out by culture tests provide low-component and, most likely, incomplete information.

Keywords

fetal growth restriction / infections in pregnancy / perinatal infections

References

[1] Russian Society of Obstetricians and Gynecologists. Insufficient fetal growth requiring maternal medical care (fetal growth restriction). Clinical recommendations. 2022. (In Russ.) [cited 2024 Jan 3] Available from: https://cr.minzdrav.gov.ru/schema/722_1

[2] Российское общество акушеров-гинекологов. Недостаточный рост плода, требующий предоставления медицинской помощи матери (задержка роста плода). Клинические рекомендации. 2022. Дата обращения: 01.03.2024. Режим доступа: https://cr.minzdrav.gov.ru/schema/722_1

[3] Posiseeva LV, Kiseleva OYu, Glik MV. Fetal growth restriction: causes and risk factors. Obstetrics and gynecology. News. Views. Education. 2021;9(2):92–99. EDN: KERKLZ doi: 10.33029/2303-9698-2021-9-2-92-99

[4] Посисеева Л.В., Киселева О.Ю., Глик М.В. Задержка роста плода: причины и факторы риска // Акушерство и гинекология. Новости. Мнения. Обучение. 2021. Т. 9, № 2(32). С. 92–99. EDN: KERKLZ doi: 10.33029/2303-9698-2021-9-2-92-99

[5] Kuklina LV, Kravchenko EN, Krivchik GV. The role of the infectious factor in the formation of fetal growth retardation and gestation outcomes. Mother and baby in Kuzbass. 2020;2(81):20–25. EDN: VNJNLI doi: 10.24411/2686-7338-2020-10017

[6] Куклина Л.В., Кравченко Е.Н., Кривчик Г.В. Роль инфекционного фактора в формировании задержки роста плода и исходы гестации // Мать и дитя в Кузбассе. 2020. № 2(81). C. 20–25. EDN: VNJNLI doi: 10.24411/2686-7338-2020-10017

[7] Dolgushina VF, Kurnosenko IV, Astashkina MV. Intrauterine infection during pregnancy. Obstetrics and Gynecology. 2021;(6):41–46. EDN: YFVVXP doi: 10.18565/aig.2021.6.41-46

[8] Долгушина В.Ф., Курносенко И.В., Асташкина М.В. Внутриматочная инфекция во время беременности // Акушерство и гинекология. 2021. № 6. С. 41–46. EDN: YFVVXP doi: 10.18565/aig.2021.6.41-46

[9] Kamphof HD, Posthuma S, Gordijn SJ, Wessel G. Fetal growth restriction: mechanisms, epidemiology, and management. Maternal-Fetal Medicine. 2022;4(3):186–196. doi: 10.1097/FM9.0000000000000161

[10] Kamphof H.D., Posthuma S., Gordijn S.J., et al. Fetal growth restriction: mechanisms, epidemiology, and management // Maternal-Fetal Medicine. 2022. Vol. 4, N. 3. P. 186–196. doi: 10.1097/FM9.0000000000000161

[11] Germain M, Krohn MA, Hillier SL, et al. Genital flora in pregnancy and its association with intrauterine growth retardation. J Clin Microbiol. 1994;32(9):2162–2168. doi: 10.1128/jcm.32.9.2162-2168.1994

[12] Germain M., Krohn M.A., Hillier S.L., et al. Genital flora in pregnancy and its association with intrauterine growth retardation // J Clin Microbiol. 1994. Vol. 32, N. 9. P. 2162–2168. doi: 10.1128/jcm.32.9.2162-2168.1994

[13] Battarbee AN, Sinkey RG, Harper LM, et al. Chronic hypertension in pregnancy. Am J Obstet Gynecol. 2020;222(6):532–541. doi: 10.1016/j.ajog.2019.11.1243

[14] Battarbee A.N., Sinkey R.G., Harper L.M., et al. Chronic hypertension in pregnancy // Am J Obstet Gynecol. 2020. Vol. 222, N. 6. P. 532–541. doi: 10.1016/j.ajog.2019.11.1243

[15] Levy M, Alberti D, Kovo M, et al. Placental pathology in pregnancies complicated by fetal growth restriction: recurrence vs. new onset. Arch Gynecol Obstet. 2020;301(6):1397–1404. doi: 10.1007/s00404-020-05546-x

[16] Levy M., Alberti D., Kovo M., et al. Placental pathology in pregnancies complicated by fetal growth restriction: recurrence vs. new onset // Arch Gynecol Obstet. 2020. Vol. 301, N. 6. P. 1397–1404. doi: 10.1007/s00404-020-05546-x

[17] Li R, Lodge J, Flatley C, et al. The burden of adverse obstetric and perinatal outcomes from maternal smoking in an Australian cohort. Aust N Z J Obstet Gynaecol. 2019;59(3):356–361. doi: 10.1111/ajo.12849

[18] Li R., Lodge J., Flatley C., et al. The burden of adverse obstetric and perinatal outcomes from maternal smoking in an Australian cohort // Aust N Z J Obstet Gynaecol. 2019. Vol. 59, N. 3. P. 356–361. doi: 10.1111/ajo.12849

[19] Shchegolev AI. Current morphological classification of damages to the placenta. Obstetrics and Gynecology. 2016;(4):16–23. (In Russ.) EDN: VWWWJN doi: 10.18565/aig.2016.4.16-23

[20] Щеголев А.И. Современная морфологическая классификация повреждений плаценты // Акушерство и гинекология. 2016. № 4. С. 16–23. EDN: VWWWJN doi: 10.18565/aig.2016.4.16-23

[21] Stupak A, Gęca T, Kwaśniewska A, et al. Comparative analysis of the placental microbiome in pregnancies with late fetal growth restriction versus physiological pregnancies. Int J Mol Sci. 2023;24(8):6922. doi: 10.3390/ijms24086922

[22] Stupak A., Gęca T., Kwaśniewska A., et al. Comparative analysis of the placental microbiome in pregnancies with late fetal growth restriction versus physiological pregnancies // Int J Mol Sci. 2023. Vol. 24, N. 8. P. 6922. doi: 10.3390/ijms24086922

[23] Prince AL, Chu DM, Seferovic MD, et al. The perinatal microbiome and pregnancy: moving beyond the vaginal microbiome. Cold Spring Harb Perspect Med. 2015;5(6). doi: 10.1101/cshperspect.a023051

[24] Prince A.L., Chu D.M., Seferovic M.D., et al. The perinatal microbiome and pregnancy: moving beyond the vaginal microbiome // Cold Spring Harb Perspect Med. 2015. Vol. 5, N. 6. doi: 10.1101/cshperspect.a023051

[25] All-Russian public organization «Russian Society of Dermatovenereologists and Cosmetologists», Russian Society of Obstetricians and Gynecologists. Urogenital trichomoniasis. Clinical recommendations. 2022. (In Russ.) [cited 2024 Jan 3] Available from: https://cr.minzdrav.gov.ru/schema/241_2

[26] Общероссийская общественная организация «Российское общество дерматовенерологов и косметологов», Российское общество акушеров-гинекологов. Урогенитальный трихомониаз. Клинические рекомендации. 2022. Дата обращения: 01.03.2024. Режим доступа: https://cr.minzdrav.gov.ru/schema/241_2

[27] All-Russian public organization «Russian Society of Dermatovenereologists and Cosmetologists», Russian Society of Obstetricians and Gynecologists. Gonococcal infection. Clinical recommendations. 2022. (In Russ.) [cited 2024 Jan 3] Available from: https://cr.minzdrav.gov.ru/schema/218_1

[28] Общероссийская общественная организация «Российское общество дерматовенерологов и косметологов», Российское общество акушеров-гинекологов. Гонококковая инфекция. Клинические рекомендации. 2022. Дата обращения: 01.03.2024. Режим доступа: https://cr.minzdrav.gov.ru/schema/218_1

RIGHTS & PERMISSIONS

Eсо-Vector